Submission date
07/01/2015
Registration date
23/02/2015
Last edited
07/03/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Retrospectively registered
Protocol added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Background and study aims
Gastric bypass surgery can help individuals who are overweight and cannot lose weight through non-surgical ways. The surgery reduces weight and increases patients’ quality of life, but some patients start to gain weight after some years or do not lose as much weight as expected. The reasons are usually poor health, shame and feelings of loss of control. The aim of this study is to reduce these problems and improve the effects of gastric bypass in women.

Who can participate?
Women who are overweight, can speak Swedish and are planning to have a gastric bypass surgery at any of our four hospitals (Ersta, Uppsala, Örebro or Danderyds) from January 2015 to November 2015

What does the study involve?
Participants are randomly allocated to receive four 1-hour sessions of group therapy about 2 months after surgery or usual care after surgery. The group sessions comprise discussions with a small task to be done at home. All participants are given an accelerometer (an instrument to measure movement) and questionnaires about eating habits, social life, happiness of life and self-esteem every 6 months until 2 years after surgery.

What are the possible benefits and risks of participating?
No known risks

Where is the study run from?
Hospitals Ersta Sjukhus, Danderyds sjukhus, Universitetssjukhuset Örebro and Akademiska sjukhuset (Sweden)

When is the study starting and how long is it expected to run for?
December 2013 to January 2018

Who is funding the study?
Karolinska Institutet (Sweden)

Who is the main contact?
Fanny Sellberg

Study website

Contact information

Type

Scientific

Contact name

Dr Daniel Berglind

ORCID ID

Contact details

Department of Public Health Sciences
Karolinska Institutet
Solnavägen
Stockholm
113 65
Sweden

Type

Public

Contact name

Ms Fanny Sellberg

ORCID ID

Contact details

Tomteboda vägen 18A
Stockholm
171 77
Sweden

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Can a dissonance-based intervention improve quality of life, social adjustment, eating behaviour and physical activity in women after gastric bypass surgery? A randomised controlled study

Acronym

WELG (study of well-being after gastric bypass)

Study hypothesis

1. Quality of life and social adjustment will be higher at follow-up in the intervention group than before surgery and higher than in the control group.
2. Fewer symptoms of disordered eating behaviours and higher body satisfaction will be noted at follow-up in the intervention group than before surgery and fewer than in the control group.
3. Physical activity and weight loss will be higher at follow-up in the intervention group than in the control group.

Ethics approval(s)

Stockholm Ethics Review Board, 10/12/2013, Dnr: 2013/1847-31/2

Study design

Randomised controlled study

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Prevention

Patient information sheet

Not available in web format, please use contact details to request a patient information sheet (in Swedish).

Condition

Prevention of unwanted mental and physical outcomes after gastric bypass surgery

Intervention

50% of the recruited patients will be randomly allocated to the intervention group after surgery and 50% to the control group (usual post-operative follow-up). The first intervention session will start about 2 months after surgery. The group sessions will consist of 1 hour discussions, role plays and other activities and will be led by a researcher. We will use a dissonance-based group setting with four 1 hour sessions (one session per week) in the intervention group, covering eating behaviour, physical activity and social and intimate relations. Other versions of this intervention have been successfully used in other settings with the same structure, for example, for the prevention of eating disorders in non-obese individuals. The theory is that the participants will discuss difficult situations that might occur after surgery and propose approaches and solutions in a group setting. It is suggested that individuals will then tend to use these approaches themselves if they face difficulties in the future.

Intervention type

Behavioural

Primary outcome measure

1. Quality of life, measured with a validated questionnaire (SF-36)
2. Eating behaviour, measured with the Three-Factor Eating Questionnaire and the Disordered Eating after Bariatric Surgery
3. Body esteem, measured with the Body Esteem Scale
4. Social adjustment, measured with the Social Adjustment Scale
5. Physical activity, measured with an accelerometer at before surgery and at 6 months, 1 year and 2 years after surgery; the accelerometers will be posted to the participants and returned in the post

All questionnaires (except SF-36) will be completed at home and emailed to the research group before surgery and at 6 months, 12 months, 18 months and 24 months after surgery. SF-36 will be measured at the same timepoints with a national register as a part of the usual care.

Secondary outcome measures

1. Weight
2. Height
3. Waist circumference

The secondary outcomes will be measured before surgery and at 6 months, 12 months, 18 months and 24 months after surgery by the nurses at the hospital where the surgery is done.

Overall study start date

01/12/2013

Overall study end date

01/08/2021

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. Eligible for gastric bypass surgery: body-mass index >35 kg/m2, usually between 18–65 (with some exceptions)
2. Aged over 18 years old
3. Able to speak and read Swedish
4. Women

Participant type(s)

Patient

Age group

Adult

Lower age limit

18 Years

Sex

Female

Target number of participants

240

Total final enrolment

259

Participant exclusion criteria

Current diagnosis of depression

Recruitment start date

15/01/2015

Recruitment end date

01/11/2015

Locations

Countries of recruitment

Sweden

Study participating centre

Ersta Sjukhus
Fjällgatan 44
Stockholm
116 91
Sweden

Study participating centre

Danderyds sjukhus
Mörbygårdsvägen, Danderyd
Stockholm
182 88
Sweden

Study participating centre

Universitetssjukhuset Örebro
Södra Grev Rosengatan
Örebro
703 62
Sweden

Study participating centre

Akademiska sjukhuset
Akademiska sjukhuset
Uppsala
751 85
Sweden

Sponsor information

Organisation

Karolinska Institute

Sponsor details

Karolinska institutet
Stockholm
171 77
Sweden

Sponsor type

University/education

Website

http://ki.se

ROR

https://ror.org/056d84691

Funders

Funder type

Government

Funder name

Karolinska Institutet

Alternative name(s)

Karolinska Institute, KI

Funding Body Type

government organisation

Funding Body Subtype

Local government

Location

Sweden

Funder name

Centre for epidimeology and social medicine

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

The study will be a part of a 4 year PhD student project with at least two publications.

Intention to publish date

01/01/2019

Individual participant data (IPD) sharing plan

Not provided at registration

IPD sharing plan summary

Not expected to be made available

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 09/05/2018 Yes No
Results article 04/11/2021 05/11/2021 Yes No
Results article 05/02/2019 07/03/2023 Yes No

Additional files

Editorial Notes

07/03/2023: Publication reference added. 05/11/2021: The following changes have been made: 1. Publication reference added. 2. The total final enrolment number has been added from the reference. 14/01/2019: The following changes were made to the trial record: 1. Publication reference added. 2. The overall trial end date was changed from 01/01/2018 to 01/08/2021.